Hansoh Pharma Re-Files for $500 Million to $1 Billion Hong Kong IPO

Hansoh Pharma, an established drug company headquartered in Lianyungang, Jiangsu province, has once again filed for a Hong Kong IPO, which is rumored to seek between $500 million and $1 billion in new capital. In September 2018, Hansoh filed to raise between $1 billion and $3 billion, but the company allowed the application to lapse after six months. Hansoh is a profitable drug company with $1.1 billion in revenue and more than $280 million in profits. More details.... Share this with colleagues: // //